Discovery & Development

How next-generation drug delivery and advanced automation are set to transform pharma’s future.

Takeda experts explore the potential of AI-driven drug discovery and the importance of including diverse patient voices in trial design.

How to meet the demand for first-in-human clinical trials using fit-for-phase formulation approaches.

How a collaboration between different organizations aims to advance perfusion for cell and gene therapies.

Researchers demonstrate anticounterfeiting method that uses DNA oligos integrated into pharmaceutical products.

Milton Boyer and Dave Stevens delve into the company’s evolution and expertise in sterile manufacturing and drug delivery systems.

How immunotherapy could redefine cancer treatment.

Regeneron’s Gary Herman discusses the future of genetic medicines and the role of new delivery systems.

From overcoming herd mentality in research to expanding cell therapy applications in cancer treatment, we explore the future of pharma.

From regulatory hurdles to patient recruitment challenges; how can pharma improve its clinical trials?